Furthermore, differential expression of miRNAs can be observed in RASopathies and has been crucial for understanding the molecular signature of malignant peripheral nerve sheath tumors (MPNSTs) compared to pNFs, as well as high-grade gliomas versus low-grade gliomas in NF1 [45,46,47]. This evidence concerns the gene NF1 and central nervous system cancer.